Overview
Top Medical Research Studies
Our comprehensive study involved optimizing different growth conditions such as pH, temperature, and nutrient sources, alongside improving the strain through UV-mutagenesis. We were excited to find that these optimizations led to a significant increase in nattokinase production.
The standout results showed that our modified strain produced nattokinase with a maximum activity of 4263 U mL(-1), which is double that of the original strain. In practical terms, this nattokinase achieved an impressive 94% blood clot lysis within ten minutes, hinting at its potential as a rapid acting treatment for heart-related issues.
Overall, our findings suggest that nattokinase from Pseudomonas aeruginosa CMSS could be a promising candidate for thrombolytic therapy, notably for those at risk of acute myocardial infarction. This unique study represents the first report of nattokinase production from this microorganism, opening the door to further research.
Nattokinase is a naturally occurring enzyme known for its ability to dissolve blood clots, but its clinical use has been limited due to stability issues. To overcome this, we developed a manganese oxide nanozyme loaded with nattokinase, called MnOx@NK. This innovative approach not only delivers the clot-busting properties of nattokinase but also provides antioxidant benefits.
In our experiments using a mouse model of heart attack, we administered MnOx@NK through tail vein injections. The results were promising: we observed significant improvements in vascular function and a notable reduction in myocardial injury. The nanozyme effectively protected against oxidative stress, which can worsen the damage caused by heart attacks.
Overall, our findings suggest that using nattokinase-loaded nanozymes may pave the way for new treatments for acute myocardial infarction, potentially offering a safer and more effective option for patients facing this severe condition.
Most Useful Reviews
Medical Researches
- All Researches
Our comprehensive study involved optimizing different growth conditions such as pH, temperature, and nutrient sources, alongside improving the strain through UV-mutagenesis. We were excited to find that these optimizations led to a significant increase in nattokinase production.
The standout results showed that our modified strain produced nattokinase with a maximum activity of 4263 U mL(-1), which is double that of the original strain. In practical terms, this nattokinase achieved an impressive 94% blood clot lysis within ten minutes, hinting at its potential as a rapid acting treatment for heart-related issues.
Overall, our findings suggest that nattokinase from Pseudomonas aeruginosa CMSS could be a promising candidate for thrombolytic therapy, notably for those at risk of acute myocardial infarction. This unique study represents the first report of nattokinase production from this microorganism, opening the door to further research.
Nattokinase is a naturally occurring enzyme known for its ability to dissolve blood clots, but its clinical use has been limited due to stability issues. To overcome this, we developed a manganese oxide nanozyme loaded with nattokinase, called MnOx@NK. This innovative approach not only delivers the clot-busting properties of nattokinase but also provides antioxidant benefits.
In our experiments using a mouse model of heart attack, we administered MnOx@NK through tail vein injections. The results were promising: we observed significant improvements in vascular function and a notable reduction in myocardial injury. The nanozyme effectively protected against oxidative stress, which can worsen the damage caused by heart attacks.
Overall, our findings suggest that using nattokinase-loaded nanozymes may pave the way for new treatments for acute myocardial infarction, potentially offering a safer and more effective option for patients facing this severe condition.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
A heart attack, also known as myocardial infarction, occurs when blood flow to a part of the heart is blocked, often by a blood clot. This interruption can damage or destroy part of the heart muscle, leading to serious health complications or death if not treated promptly. Common symptoms include chest pain, shortness of breath, nausea, and lightheadedness. Risk factors include high blood pressure, high cholesterol, smoking, diabetes, and a sedentary lifestyle.
Preventing a heart attack largely revolves around maintaining a heart-healthy lifestyle. Regular exercise, a balanced diet rich in fruits, vegetables, whole grains, and lean proteins, along with managing stress, can significantly lower the risk. Furthermore, understanding your personal risk factors and engaging with healthcare professionals for regular check-ups can be crucial in both prevention and early detection. If you suspect someone is having a heart attack, it's important to call emergency services immediately, as timely treatment is vital for survival and recovery.
Nattokinase is an enzyme extracted from a traditional Japanese food called natto, which is made from fermented soybeans. This enzyme is thought to have potential health benefits, primarily for cardiovascular health. Nattokinase is believed to support the breakdown of fibrin in the blood, which can help improve circulation and reduce the risk of blood clot formation. As a dietary supplement, it is often marketed for its possible ability to promote healthy blood flow and cardiovascular function.
While some studies suggest that nattokinase may help reduce blood pressure and enhance overall heart health, research is still ongoing. As with any supplement, it is essential to consult with a healthcare professional before adding nattokinase to your regimen, especially if you are on blood-thinning medications or have underlying health conditions. Overall, while nattokinase might offer some intriguing health benefits, more comprehensive studies are needed to fully understand its efficacy and safety profile.
Based on user reviews, it seems that many individuals start noticing positive results from this supplement within a week of consistent use. For instance, one reviewer mentioned feeling more capable of walking and experiencing a significant reduction in shortness of breath after adhering to the dosage for about a week (Read Review). Similarly, another user reported improvements in physical strength within the same timeframe, especially when combining the supplement with other heart health aids (Read Review).
While individual experiences may vary, these early positive outcomes suggest that users can expect to see beneficial effects fairly quickly—typically within the first week. The supplement appears to be well-regarded for its ability to support cardiovascular functions and improve circulation, making it a popular choice among those looking to enhance heart health (Read Review).
Recent scientific studies highlight the potential of nattokinase, an enzyme known for its ability to dissolve blood clots, as a promising treatment for heart attacks. In one study, researchers developed a manganese oxide nanozyme loaded with nattokinase and tested its efficacy in a mouse model of acute myocardial infarction. Results showed significant improvements in vascular function and reductions in myocardial injury, suggesting that this innovative approach could enhance the delivery and effectiveness of nattokinase in combating heart attacks by mitigating oxidative stress associated with heart damage [1].
Another study focused on optimizing the production of nattokinase from a strain of Pseudomonas aeruginosa, achieving a remarkable increase in enzyme activity. This modified strain demonstrated the ability to lyse 94% of blood clots within ten minutes, indicating its rapid action as a potential thrombolytic therapy, especially for patients at risk of acute myocardial infarction [2]. Together, these findings underscore the scientific support for nattokinase as a valuable supplement in heart attack treatment.
According to user reviews, many individuals have reported significant improvements in their symptoms after using this supplement. Users noted a variety of benefits, including enhanced walking capabilities and a reduction in shortness of breath within just a week of consistent use (Read Review). Another reviewer highlighted improvements in physical strength, particularly for those dealing with post-COVID effects such as heart palpitations when the supplement was taken in conjunction with other heart health aids like bromelain and coenzyme Q10 (Read Review).
Many users also emphasized the supplement's role in supporting cardiovascular functions and enhancing blood circulation, making it a popular choice for individuals concerned about heart health (Read Review). Improving symptoms associated with thrombosis and inflammation were also mentioned, affirming its broad therapeutic potential (Read Review). It’s important to note, however, that individual results can vary, and while many users report positive outcomes, experiences may differ.
Based on user reviews, many individuals have reported positive experiences when combining this supplement with other heart health aids. Users have specifically highlighted the complementary effects of serrapeptase and nattokinase, particularly in addressing symptoms associated with post-COVID conditions like heart palpitations. One reviewer noted considerable improvements in physical strength after taking the supplement alongside bromelain and coenzyme Q10, indicating a synergistic benefit in managing symptoms related to heart health issues (Read Review).
Moreover, numerous users acknowledged the effectiveness of this supplement in enhancing cardiovascular function and circulation, suggesting it may be beneficial in managing conditions such as thrombosis and inflammation (Read Review). Overall, the complementarity of this supplement with other quality ingredients has led to a favorable reception from users looking to optimize their heart health and manage related symptoms.
Based on user reviews, the appropriate dosage for Nattokinase when used for heart health and related issues seems to yield positive outcomes without specific recommendations for precise dosing. Users have reported noticing significant benefits shortly after starting the supplement, often within a week of adhering to the suggested dosage. One user noted a reduction in shortness of breath and increased capability in walking after using the supplement regularly, asserting its value for heart patients and those with tachycardia (Read Review).
Additionally, another user took Nattokinase in combination with other supplements like bromelain and coenzyme Q10, which also showed improvements in physical strength and alleviated symptoms like heart palpitations (Read Review). This trend suggests that while users advocate for Nattokinase as a beneficial supplement for cardiovascular support, specific dosing details may vary and are typically aligned with general usage directions provided on the product packaging. For those considering Nattokinase, it might be worthwhile to monitor personal health responses closely when beginning supplementation.
Nattokinase is a naturally occurring enzyme known for its ability to dissolve blood clots, but its clinical use has been limited due to stability issues. To overcome this, we developed a manganese oxide nanozyme loaded with nattokinase, called MnOx@NK. This innovative approach not only delivers the clot-busting properties of nattokinase but also provides antioxidant benefits.
In our experiments using a mouse model of heart attack, we administered MnOx@NK through tail vein injections. The results were promising: we observed significant improvements in vascular function and a notable reduction in myocardial injury. The nanozyme effectively protected against oxidative stress, which can worsen the damage caused by heart attacks.
Overall, our findings suggest that using nattokinase-loaded nanozymes may pave the way for new treatments for acute myocardial infarction, potentially offering a safer and more effective option for patients facing this severe condition.
Our comprehensive study involved optimizing different growth conditions such as pH, temperature, and nutrient sources, alongside improving the strain through UV-mutagenesis. We were excited to find that these optimizations led to a significant increase in nattokinase production.
The standout results showed that our modified strain produced nattokinase with a maximum activity of 4263 U mL(-1), which is double that of the original strain. In practical terms, this nattokinase achieved an impressive 94% blood clot lysis within ten minutes, hinting at its potential as a rapid acting treatment for heart-related issues.
Overall, our findings suggest that nattokinase from Pseudomonas aeruginosa CMSS could be a promising candidate for thrombolytic therapy, notably for those at risk of acute myocardial infarction. This unique study represents the first report of nattokinase production from this microorganism, opening the door to further research.
References
- Shi Y, Liu C, Gui Y, Guo Y, Zhang Y, et al. A Nattokinase-Loaded Nanozyme for Alleviating Acute Myocardial Infarction via Thrombolysis and Antioxidation. Adv Healthc Mater. 2024. doi:10.1002/adhm.202402763
- Chandrasekaran SD, Vaithilingam M, Shanker R, Kumar S, Thiyur S, et al. Exploring the In Vitro Thrombolytic Activity of Nattokinase From a New Strain Pseudomonas aeruginosa CMSS. Jundishapur J Microbiol. 2015;8:e23567. doi:10.5812/jjm.23567
